If it seems like everyone in the drug development field is talking about patient centricity, it’s probably because it’s true. Pharmaceutical firms, research sites, data management solutions providers, and patients themselves all are focusing more than ever before on how to ensure that clinical trials, from end to end, put the patient at the center of their efforts.
On November 17, Outsourcing-Pharma is hosting a group of respected industry experts to take the issues associated with patient centricity head-on. Register for the online event Patient-centric Solutions (happening 10 am CT or 5 pm CET) and you’ll get a chance to listen in on their well-informed conversation, and to weigh in with your own thoughts and questions.
The organizations represented in our panel of speakers are important players in the field of clinical research, each with a focus on patient centricity.
Ieuan Clay, chief scientific officer, Digital Medicine Society (DiMe)
Clay comes from DiMe, an organization with the mission of bringing together experts from across the landscape of digital medicine. They seek to encourage collaboration on the future direction of the field, with the hopes of ultimately benefiting the patient.
Before joining Dime, Clay worked for Evidation Health. There, his list of accomplishments includes working to build heart health programs, in partnership with the American College of Cardiology.
Erin Leckrone, senior director of clinical trials, Be the Match/Center for International Bone and Marrow Transplant Research
Brenna O’Brien, clinical trials patient navigator, Be the Match
Be the Match is likely best known for its registry, which seeks to match patients diagnosed with a range of conditions and hopeful volunteer donors. They will be enlightening attendees on the organization’s important work in clinical development.
Sanofi, Be the Match, and DiMe to weigh in on patient centricity - OutSourcing-Pharma.com
Read More
No comments:
Post a Comment